Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

CD39+Regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism

Authors: Zhi-Jian Ye, Qiong Zhou, Jian-Chu Zhang, Xiao Li, Cong Wu, Shou-Ming Qin, Jian-Bao Xin, Huan-Zhong Shi

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Both regulatory T cells (Tregs) and T helper IL-17-producing cells (Th17 cells) have been found to be involved in human malignancies, however, the possible implication of Tregs in regulating generation and differentiation of Th17 cells in malignant pleural effusion remains to be elucidated.

Methods

The numbers of both CD39+Tregs and Th17 cells in malignant pleural effusion and peripheral blood from patients with lung cancer were determined by flow cytometry. The regulation and mechanism of Tregs on generation and differentiation of Th17 cells were explored.

Results

Both CD39+Tregs and Th17 cells were increased in malignant pleural effusion when compared with blood, and the numbers of CD39+Tregs were correlated negatively with those of Th17 cells. It was also noted that high levels of IL-1β, IL-6, and TGF-β1 could be observed in malignant pleural effusion when compared the corresponding serum, and that pleural CD39+Tregs could express latency-associated peptide on their surface. When naïve CD4+ T cells were cocultured with CD39+Tregs, Th17 cell numbers decreased as CD39+Treg numbers increased, addition of the anti-latency-associated peptide mAb to the coculture reverted the inhibitory effect exerted by CD39+Tregs.

Conclusions

Therefore, the above results indicate that CD39+Tregs inhibit generation and differentiation of Th17 cells via a latency-associated peptide-dependent mechanism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Light RW: Clinical practice. Pleural effusion. N Engl J Med. 2002, 346: 1971-1977. 10.1056/NEJMcp010731.CrossRefPubMed Light RW: Clinical practice. Pleural effusion. N Engl J Med. 2002, 346: 1971-1977. 10.1056/NEJMcp010731.CrossRefPubMed
2.
go back to reference Lucivero G, Pierucci G, Bonomo L: Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J. 1988, 1: 337-340.PubMed Lucivero G, Pierucci G, Bonomo L: Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J. 1988, 1: 337-340.PubMed
3.
go back to reference Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T: The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 2004, 95: 697-703. 10.1111/j.1349-7006.2004.tb03248.x.CrossRefPubMed Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T: The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 2004, 95: 697-703. 10.1111/j.1349-7006.2004.tb03248.x.CrossRefPubMed
4.
go back to reference Atanackovic D, Block A, de WA, Faltz C, Hossfeld DK, Hegewisch-Becker S: Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res. 2004, 10: 2600-2608. 10.1158/1078-0432.CCR-03-0239.CrossRefPubMed Atanackovic D, Block A, de WA, Faltz C, Hossfeld DK, Hegewisch-Becker S: Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res. 2004, 10: 2600-2608. 10.1158/1078-0432.CCR-03-0239.CrossRefPubMed
5.
go back to reference Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed
6.
go back to reference Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336.CrossRefPubMed Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336.CrossRefPubMed
7.
go back to reference Mills KH: Induction, function and regulation of IL-17-producing T cells. Eur J Immunol. 2008, 38: 2636-2649. 10.1002/eji.200838535.CrossRefPubMed Mills KH: Induction, function and regulation of IL-17-producing T cells. Eur J Immunol. 2008, 38: 2636-2649. 10.1002/eji.200838535.CrossRefPubMed
8.
go back to reference Weaver CT, Hatton RD: Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009, 9: 883-889. 10.1038/nri2660.CrossRefPubMed Weaver CT, Hatton RD: Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009, 9: 883-889. 10.1038/nri2660.CrossRefPubMed
9.
go back to reference Chen YQ, Shi HZ, Qin XJ, Mo WN, Liang XD, Huang ZX, Yang HB, Wu C: CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med. 2005, 172: 1434-1439. 10.1164/rccm.200504-588OC.CrossRefPubMed Chen YQ, Shi HZ, Qin XJ, Mo WN, Liang XD, Huang ZX, Yang HB, Wu C: CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med. 2005, 172: 1434-1439. 10.1164/rccm.200504-588OC.CrossRefPubMed
10.
go back to reference Qin XJ, Shi HZ, Liang QL, Liu GN, Jiang J, Qin SM, Deng JM, Ye ZJ: CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res. 2009, 15: 2231-2237. 10.1158/1078-0432.CCR-08-2641.CrossRefPubMed Qin XJ, Shi HZ, Liang QL, Liu GN, Jiang J, Qin SM, Deng JM, Ye ZJ: CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res. 2009, 15: 2231-2237. 10.1158/1078-0432.CCR-08-2641.CrossRefPubMed
11.
go back to reference Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN, Shi HZ: Generation and differentiation of interleukin-17-producing CD4+ T cells in malignant pleural effusion. J Immunol. 2010, 185: 6348-6354. 10.4049/jimmunol.1001728.CrossRefPubMed Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN, Shi HZ: Generation and differentiation of interleukin-17-producing CD4+ T cells in malignant pleural effusion. J Immunol. 2010, 185: 6348-6354. 10.4049/jimmunol.1001728.CrossRefPubMed
12.
go back to reference Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I: Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008, 112: 2340-2352. 10.1182/blood-2008-01-133967.CrossRefPubMed Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I: Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008, 112: 2340-2352. 10.1182/blood-2008-01-133967.CrossRefPubMed
13.
go back to reference Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB: TGF-beta latency: biological significance and mechanisms of activation. Stem Cells. 1997, 15: 190-197. 10.1002/stem.150190.CrossRefPubMed Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB: TGF-beta latency: biological significance and mechanisms of activation. Stem Cells. 1997, 15: 190-197. 10.1002/stem.150190.CrossRefPubMed
14.
go back to reference Lawrence DA: Latent-TGF-beta: an overview. Mol Cell Biochem. 2001, 219: 163-170. 10.1023/A:1010819716023.CrossRefPubMed Lawrence DA: Latent-TGF-beta: an overview. Mol Cell Biochem. 2001, 219: 163-170. 10.1023/A:1010819716023.CrossRefPubMed
15.
go back to reference Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V: A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol. 2008, 9: 650-657.CrossRefPubMed Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V: A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol. 2008, 9: 650-657.CrossRefPubMed
16.
go back to reference Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA: IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature. 2008, 454: 350-352. 10.1038/nature07021.CrossRefPubMedPubMedCentral Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA: IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature. 2008, 454: 350-352. 10.1038/nature07021.CrossRefPubMedPubMedCentral
17.
go back to reference Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F: Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007, 8: 942-949.CrossRefPubMed Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F: Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007, 8: 942-949.CrossRefPubMed
18.
go back to reference Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF: Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA. 2008, 105: 15505-15510. 10.1073/pnas.0710686105.CrossRefPubMedPubMedCentral Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF: Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA. 2008, 105: 15505-15510. 10.1073/pnas.0710686105.CrossRefPubMedPubMedCentral
19.
go back to reference Chen W, Konkel JE: TGF-β and 'adaptive' Foxp3+ regulatory T cells. J Mol Cell Biol. 2010, 2: 30-36. 10.1093/jmcb/mjp004.CrossRefPubMed Chen W, Konkel JE: TGF-β and 'adaptive' Foxp3+ regulatory T cells. J Mol Cell Biol. 2010, 2: 30-36. 10.1093/jmcb/mjp004.CrossRefPubMed
20.
go back to reference Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001, 194: 629-644. 10.1084/jem.194.5.629.CrossRefPubMedPubMedCentral Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001, 194: 629-644. 10.1084/jem.194.5.629.CrossRefPubMedPubMedCentral
21.
go back to reference Oida T, Xu L, Weiner HL, Kitani A, Strober W: TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol. 2006, 177: 2331-2339.CrossRefPubMed Oida T, Xu L, Weiner HL, Kitani A, Strober W: TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol. 2006, 177: 2331-2339.CrossRefPubMed
22.
go back to reference Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA: IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009, 113: 4240-4249. 10.1182/blood-2008-10-183251.CrossRefPubMedPubMedCentral Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA: IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009, 113: 4240-4249. 10.1182/blood-2008-10-183251.CrossRefPubMedPubMedCentral
23.
go back to reference Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ: Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA. 2009, 106: 4793-4798. 10.1073/pnas.0900408106.CrossRefPubMedPubMedCentral Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ: Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA. 2009, 106: 4793-4798. 10.1073/pnas.0900408106.CrossRefPubMedPubMedCentral
24.
go back to reference Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, Valmori D: Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt. Proc Natl Acad Sci USA. 2009, 106: 8635-8640. 10.1073/pnas.0900621106.CrossRefPubMedPubMedCentral Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, Valmori D: Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt. Proc Natl Acad Sci USA. 2009, 106: 8635-8640. 10.1073/pnas.0900621106.CrossRefPubMedPubMedCentral
25.
go back to reference Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441: 235-238. 10.1038/nature04753.CrossRefPubMed Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441: 235-238. 10.1038/nature04753.CrossRefPubMed
26.
go back to reference Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006, 24: 179-189. 10.1016/j.immuni.2006.01.001.CrossRefPubMed Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006, 24: 179-189. 10.1016/j.immuni.2006.01.001.CrossRefPubMed
27.
go back to reference Xu L, Kitani A, Fuss I, Strober W: Cutting edge: regulatory T cells induce CD4+CD25+Foxp3+ T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol. 2007, 178: 6725-6729.CrossRefPubMed Xu L, Kitani A, Fuss I, Strober W: Cutting edge: regulatory T cells induce CD4+CD25+Foxp3+ T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol. 2007, 178: 6725-6729.CrossRefPubMed
28.
go back to reference Deknuydt F, Bioley G, Valmori D, Ayyoub M: IL-1β and IL-2 convert human Treg into TH17 cells. Clin Immunol. 2009, 131: 298-307. 10.1016/j.clim.2008.12.008.CrossRefPubMed Deknuydt F, Bioley G, Valmori D, Ayyoub M: IL-1β and IL-2 convert human Treg into TH17 cells. Clin Immunol. 2009, 131: 298-307. 10.1016/j.clim.2008.12.008.CrossRefPubMed
29.
go back to reference Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G, Reis e Sousa C: DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol. 2008, 38: 3274-3281. 10.1002/eji.200838950.CrossRefPubMedPubMedCentral Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G, Reis e Sousa C: DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol. 2008, 38: 3274-3281. 10.1002/eji.200838950.CrossRefPubMedPubMedCentral
30.
go back to reference Radhakrishnan S, Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol. 2008, 181: 3137-3147.CrossRefPubMedPubMedCentral Radhakrishnan S, Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol. 2008, 181: 3137-3147.CrossRefPubMedPubMedCentral
31.
go back to reference Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004, 10: 942-949. 10.1038/nm1093.CrossRefPubMed Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004, 10: 942-949. 10.1038/nm1093.CrossRefPubMed
32.
go back to reference Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 2009, 114: 1141-1149. 10.1182/blood-2009-03-208249.CrossRefPubMedPubMedCentral Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W: Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 2009, 114: 1141-1149. 10.1182/blood-2009-03-208249.CrossRefPubMedPubMedCentral
33.
go back to reference Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006, 203: 1701-1711. 10.1084/jem.20060772.CrossRefPubMedPubMedCentral Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006, 203: 1701-1711. 10.1084/jem.20060772.CrossRefPubMedPubMedCentral
34.
go back to reference Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE: Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol. 2005, 66: 13-20.CrossRefPubMed Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE: Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol. 2005, 66: 13-20.CrossRefPubMed
35.
go back to reference Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007, 110: 1225-1232. 10.1182/blood-2006-12-064527.CrossRefPubMed Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K: Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007, 110: 1225-1232. 10.1182/blood-2006-12-064527.CrossRefPubMed
36.
go back to reference Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007, 204: 1257-1265. 10.1084/jem.20062512.CrossRefPubMedPubMedCentral Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007, 204: 1257-1265. 10.1084/jem.20062512.CrossRefPubMedPubMedCentral
37.
go back to reference Mandapathil M, Lang S, Gorelik E, Whiteside TL: Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods. 2009, 346: 55-63. 10.1016/j.jim.2009.05.004.CrossRefPubMedPubMedCentral Mandapathil M, Lang S, Gorelik E, Whiteside TL: Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods. 2009, 346: 55-63. 10.1016/j.jim.2009.05.004.CrossRefPubMedPubMedCentral
38.
go back to reference Robson SC, Sévigny J, Zimmermann H: The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2006, 2: 409-430. 10.1007/s11302-006-9003-5.CrossRefPubMedPubMedCentral Robson SC, Sévigny J, Zimmermann H: The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2006, 2: 409-430. 10.1007/s11302-006-9003-5.CrossRefPubMedPubMedCentral
39.
go back to reference Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY: CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009, 326: 986-991. 10.1126/science.1172702.CrossRefPubMedPubMedCentral Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY: CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009, 326: 986-991. 10.1126/science.1172702.CrossRefPubMedPubMedCentral
40.
go back to reference Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH: CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol. 2009, 183: 7602-7610. 10.4049/jimmunol.0901881.CrossRefPubMed Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH: CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol. 2009, 183: 7602-7610. 10.4049/jimmunol.0901881.CrossRefPubMed
Metadata
Title
CD39+Regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism
Authors
Zhi-Jian Ye
Qiong Zhou
Jian-Chu Zhang
Xiao Li
Cong Wu
Shou-Ming Qin
Jian-Bao Xin
Huan-Zhong Shi
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-77

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.